Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Prospective, Single Blinded Study for Predicting Colon Polyp Histology With Narrow Band Imaging

for
Colonoscopy, Adenomatous Polyp, Neoplastic
Location: Kansas City MO
Sponsor: Midwest Biomedical Research Foundation

Sex: All

Age: 18+

Code: NCT00613262

Recruiting

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

for
Brain Metastases, Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05064280

Phase 2, Recruiting

Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.

for
Advanced and/or Metastatic Solid Tumours
Location: Seattle WA
Sponsor: Crescendo Biologics Ltd.

Sex: All

Age: 18+

Code: NCT04839991

Phase 1, Recruiting

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

for
Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC),
Location: North Haven CT, Lake Success NY, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06413680

Phase 1, Phase 2, Recruiting

Dose-escalation Study of Oral CX-4945

for
Advanced Solid Tumors, Breast Cancer,
Location: Houston TX, Fort Collins CO, Loveland CO, Scottsdale AZ
Sponsor: Cylene Pharmaceuticals

Sex: All

Age: 18+

Code: NCT00891280

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations

for
Chronic Disease, Infectious Disorder
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04160429

Recruiting

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

for
Pathologic Processes, Diabetes Mellitus,
Location: Metairie LA
Sponsor: C5 Biomedical

Sex: All

Age: 18+

Code: NCT06674980

Recruiting

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

for
Asthma, Atherosclerosis, Metabolic Syndrome, Insulin Resistance,
Location: Research Triangle Park NC
Sponsor: National Institute of Environmental Health Sciences (NIEHS)

Sex: All

Age: 18 - 70+

Code: NCT01143480

Recruiting

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

for
Solid Tumor, Adult, Healthy Donors, COVID-19 Donors
Location: Huntersville NC
Sponsor: BioCytics, Inc.

Sex: All

Age: 5+

Code: NCT00571389

Recruiting

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Washington D.C. DC, Durham NC, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 70+

Code: NCT05868629

Recruiting

Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

for
Prostate Cancer, Refractory Cancer,
Location: Winston-Salem NC, Salisbury NC
Sponsor: Wake Forest University Health Sciences

Sex: Male

Age: 18+

Code: NCT04337580

Phase 2, Recruiting

Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

for
Non-hematologic Cancer
Location: Boise ID
Sponsor: Sequenom, Inc.

Sex: All

Age: 18+

Code: NCT02586389

Recruiting

Study of SGR-3515 In Participants With Advanced Solid Tumors.

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Fairfax VA, Toronto,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT06463340

Phase 1, Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

for
Neoplasms, Tenosynovial Giant Cell Tumor
Location: Beverly Hills CA
Sponsor: Abbisko Therapeutics Co, Ltd

Sex: All

Age: 18+

Code: NCT04192344

Phase 1, Recruiting

Cryopreservation of Ovarian Tissue

for
Cancer, Risk of Premature Ovarian Failure,
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 0 - 45

Code: NCT01558544

Recruiting

Cancer Genetic Testing in Ethnic Populations

for
Breast Carcinoma, Carcinoma of Unknown Primary,
Location: Jacksonville FL, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04475640

Recruiting

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Margate FL, San Antonio TX, Beverly Hills CA
Sponsor: Pyrotech Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06244992

Phase 1, Phase 2, Recruiting

INTERogating Cancer for Etiology, Prevention and Therapy Navigation

for
Cancer, Cancer Gene Mutation, PAN Gene Mutation,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06008392

Recruiting

Lurbinectedin in FET-Fused Tumors

for
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor,
Location: Boston MA, New York NY, Philadelphia PA, Ann Arbor MI,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10+

Code: NCT05918640

Phase 1, Phase 2, Recruiting

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Pittsburgh PA, Houston TX, Newport Beach CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT05372640

Phase 1, Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial